Clearance of Patients Sample Clauses

Clearance of Patients. Except as otherwise provided herein, CHC agrees that it will not commit to provide Drug Therapy Goods, or related services, to any patient until such patient is approved by Supplier as eligible for third party reimbursement. CHC shall promptly notify Supplier as to any potential patient and CHC shall obtain such patient data as shall be specified by Supplier. Supplier agrees to promptly contact the third party payor, investigate a potential patient's insurance coverage and financial ability to pay, obtain prior authorization, and notify CHC if the potential patient is approved to purchase Drug Therapy Goods, or related services, from CHC. CHC shall thereafter obtain all documentation necessary to file claims with third party payors and forward same to Supplier. In the case of any potential patient who is not approved, Supplier shall notify CHC of the reasons for such disapproval. Supplier shall have no liability for relying upon information provided by third party payors concerning coverage in the event that such information shall subsequently prove to be incorrect.
Sample 1
AutoNDA by SimpleDocs
Clearance of Patients. Company understands and agrees that it is Company's exclusive responsibility to determine whether an individual is an Approved Patient of the Company as defined herein. Prior to dispensing any outpatient drugs, Company shall inform THPR whether the individual is an Approved Patient of the Company. If an individual is no longer an Approved Patient of the Company, Company shall inform THPR, in writing, within 2 days of the change in status. Company understands that THPR shall rely upon Company's determination as to whether an individual is an Approved Patient of the Company who is entitled to receive outpatient drugs at Section 340B pricing under the Public Health Services Act. The Company shall promptly notify THPR as to any potential patient and shall obtain such patient data as shall be specified by THPR. THPR agrees to promptly investigate a potential patient's insurance coverage and financial ability to pay and to notify the Company as to whether said patient is approved to purchase Hemophilia Therapy Goods, or related services, from the Company. Company shall thereafter assist THPR in obtaining all documentation necessary to file claims with third party payors and forward same to THPR. THPR shall have no liability for relying upon information provided by third party payors concerning coverage in the event that such information shall subsequently prove to be
Sample 1Sample 2
Clearance of Patients. SHS agrees that it will not commit to provide Drugs or related services to any patient until such patient is approved by THPR. THPR shall promptly notify SHS as to any potential patient and shall obtain such patient data as shall be specified by SHS. SHS agrees to promptly investigate a potential patient's insurance coverage and financial ability to pay and to notify THPR as to the patient's financial ability to pay for Drugs or related services from THPR. THPR shall thereafter obtain all documentation necessary to file claims with third party payors and forward same to SHS. SHS shall have no liability for relying upon information provided by third party payors concerning coverage in the event that such information shall subsequently prove to be incorrect.
Sample 1Sample 2

Related to Clearance of Patients

  • Maintenance of Patents 12 5.5. Prosecution of Patent Application................................................. 12 5.6.

  • Prosecution and Maintenance of Patents Patent Costs ----------------------------------------------------

  • Litigation and Regulatory Cooperation During and after the Executive’s employment, the Executive shall cooperate fully with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by the Company. The Executive’s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times. During and after the Executive’s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any reasonable out-of-pocket expenses incurred in connection with the Executive’s performance of obligations pursuant to this Section 7(f).

  • Filing, Prosecution and Maintenance of Patents RENOVIS agrees to file, prosecute and maintain in the Territory, upon appropriate consultation with MERCK, the RENOVIS Patent Rights licensed to MERCK under this Agreement; provided, however, with respect to Joint Information and Inventions that are not Improvements to RENOVIS Patent Rights or RENOVIS Technology, MERCK shall have the first right to file patent applications for such Joint Information and Inventions. With respect to RENOVIS Information and Inventions, RENOVIS may elect not to file and if so MERCK shall have the right to file patent applications. In such event, RENOVIS shall execute such documents and perform such acts at RENOVIS’ expense as may be reasonably necessary to effect an assignment of such Patent Rights to MERCK in a timely manner to allow MERCK to continue such prosecution or maintenance. In each case, the filing Party shall give the non-filing Party an opportunity to review the text of the application before filing, shall consult with the non-filing Party with respect thereto, and shall supply the non-filing Party with a copy of the application as filed, together with notice of its filing date and serial number. RENOVIS shall keep MERCK advised of the status of the actual and prospective patent filings and upon the request of MERCK, provide advance copies of any papers related to the filing, prosecution and maintenance of such patent filings. RENOVIS shall promptly give notice to MERCK of the grant, lapse, revocation, surrender, invalidation or abandonment of any Patent Rights licensed to MERCK for which RENOVIS is responsible for the filing, prosecution and maintenance. With respect to all filings hereunder, the filing Party shall be responsible for payment of all costs and expenses related to such filings.

  • Prosecution and Maintenance of Patent Rights ALNYLAM will have the right and responsibility to file, prosecute and maintain patent protection in the Territory for all ALNYLAM Patent Rights. [ * ]

  • Maintenance of Physical Damage Insurance Policies The Servicer shall, in accordance with its customary servicing procedures and underwriting standards, require that each Obligor shall have obtained physical damage insurance covering each Financed Vehicle as of the origination of the related Receivable.

  • MAINTENANCE OF AGENCY So long as any of the Debentures remain Outstanding, the Company shall maintain, or shall cause to be maintained, an office or agency in the Borough of Manhattan, The City of New York, and at such other location or locations as may be designated as provided in this Section 5.2, where (i) Debentures may be presented for payment; (ii) Debentures may be presented as hereinabove authorized for registration of transfer and exchange; and (iii) notices and demands to or upon the Company in respect of the Debentures and this Indenture may be given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by its President or an Executive Vice President and delivered to the Trustee, designate some other office or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands. In addition to any such office or agency, the Company may from time to time designate one or more offices or agencies outside of the Borough of Manhattan, The City of New York, where the Debentures may be presented for registration or transfer and for exchange in the manner provided herein, and the Company may from time to time rescind such designation as the Company may deem desirable or expedient; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain any such office or agency in the Borough of Manhattan, The City of New York, for the purposes above mentioned. The Company shall give the Trustee prompt written notice of any such designation or rescission thereof.

  • Maintenance of Agencies (a) With respect to each series of Certificates, there shall at all times be maintained an office or agency in the location set forth in Section 12.04 where Certificates of such series may be presented or surrendered for registration of transfer or for exchange, and for payment thereof, and where notices and demands, to or upon the Trustee in respect of such Certificates or this Agreement may be served; provided, however, that, if it shall be necessary that the Trustee maintain an office or agency in another location with respect to the Certificates of any series (e.g., the Certificates of such series shall be represented by Definitive Certificates and shall be listed on a national securities exchange), the Trustee will make all reasonable efforts to establish such an office or agency. Written notice of the location of each such other office or agency and of any change of location thereof shall be given by the Trustee to the Company, any Owner Trustees, the Loan Trustees (in the case of any Owner Trustee or Loan Trustee, at its address specified in the Note Documents or such other address as may be notified to the Trustee) and the Certificateholders of such series. In the event that no such office or agency shall be maintained or no such notice of location or of change of location shall be given, presentations and demands may be made and notices may be served at the Corporate Trust Office of the Trustee.

  • Filing Prosecution and Maintenance of Patent Rights 7.1 Patent Filing, Prosecution and Maintenance.

  • Acceptance of Agency The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

Time is Money Join Law Insider Premium to draft better contracts faster.